CCL20 and triple-A syndrome: No differences in CCL20 local mRNA levels between positive and negative individuals for women, dyslipemia, hypertension, PAD, ischemic heart disease, antiplatelet drug user and statin user in neither normal aorta nor AAA groups were also found.